Site icon pharmaceutical daily

South African Pharmaceutical Industry Market Report 2022: Profiles of 129 Companies including Cipla, Novartis, Johnson & Johnson, Pfizer, Aspen and Adcock Ingram – ResearchAndMarkets.com

BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Industry in South Africa 2022” report has been added to ResearchAndMarkets.com’s offering.

The importance of the pharmaceutical industry has been amplified by the global health crisis. South Africa has the world’s largest antiretroviral programme and is one of the major producers of radiopharmaceuticals. With the ongoing development of local manufacturing capacity and capabilities, local pharmaceutical companies are set to play a pivotal role in the production and supply of COVID-19 vaccines and other medicines for the domestic market and the rest of Africa. Although South Africa is the largest manufacturer and supplier of pharmaceuticals in sub-Saharan Africa, it is highly reliant on imported products, which account for more than two-thirds of pharmaceutical sales.

The pandemic continues to cause business interruptions and supply chain challenges. Commercial flight disruptions have caused procurement delays and stock shortages. Other key challenges include frequent power outages and downward pressure on the rand, which has driven up the price of imported ingredients and finished products. The single exit price increase was well below inflation and the prior year increase.

Formal and informal sales revenue of all cannabis products was estimated at around R14bn in 2021 and the Department of Trade Industry and Competition said sales could double by 2024. Government’s cannabis masterplan aims to expand the cannabis industry, attract foreign investment and create tens of thousands of jobs. Many companies hope to be part of this growth, and there are around 30 licensed commercial cannabis producers in South Africa.

This report focuses on the pharmaceutical industry in South Africa including manufacture, retail and wholesale trade in pharmaceuticals and alternative health products, such as medicinal cannabis. The report includes information on the state and size of the industry, notable players in each subsector, developments, corporate actions, regulations and other influencing factors.

There are profiles of 129 companies including international companies Cipla, Novartis, Johnson & Johnson and Pfizer, local companies including Aspen and Adcock Ingram, retailers Clicks and Dis-Chem, and cannabis companies such as Goodleaf.

Key Topics Covered:

1. INTRODUCTION

2. DESCRIPTION OF THE INDUSTRY

2.1. Industry Value Chain

2.2. Geographic Position

2.4. Key Success Factors and Pain Points

3. LOCAL

3.1. Key Trends

3.2. Notable Players

3.3. Trade

3.4. Corporate Actions

3.5. Regulations

3.6. Enterprise Development and Social Economic Development

4. AFRICA

5. INTERNATIONAL

6. INFLUENCING FACTORS

6.1. COVID -19

6.2. Economic Environment

6.3. Labour

6.4. Environmental Issues

6.5. Technology, Research and Development (R&D) and Innovation

6.6. Government Support

6.7. Drug Abuse and Other Health Concerns

7. COMPETITIVE ENVIRONMENT

8. SWOT ANALYSIS

9. OUTLOOK

10. INDUSTRY ASSOCIATIONS

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/i16bbk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version